优化术后抗凝剂管理:平衡血栓栓塞和出血风险
Khyati Patel1,2, Sean P Kane1,2
1Khyati Patel, PharmD, BCACP, Associate Professor, Ambulatory Care Pharmacist, Department of Pharmacy Practice, College of Pharmacy, Rosalind Franklin University of Medicine and Science, Family Practice Clinic, Advocate Aurora Medical Center, Kenosha, Wisconsin.
Orthopedic nursing
|September 23, 2025
概括
管理手术的抗凝药包括平衡出血和凝血风险. 周术策略取决于患者因素,手术类型和使用的抗凝剂,护士发挥关键作用.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 手术护理 医疗护理
背景情况:
- 抗凝药的外科治疗需要仔细考虑血栓栓塞和出血风险.
- 由于患者的不同因素和程序特征,个性化策略至关重要.
研究的目的:
- 概述手术过程中对抗凝血中断的管理原则.
- 详细说明对血栓栓塞和出血的风险评估策略.
- 强调医疗保健专业人员,特别是护士在外科手术期间抗凝管理中的作用.
主要方法:
- 对影响术后抗凝决定的因素的审查.
- 基于出血风险的手术程序的分类 (高,低至中等,最小).
- 考虑抗凝性质 (作用持续时间,开始).
主要成果:
- 血栓塞栓症风险评估依赖于抗凝药指示和患者特定因素.
- 出血风险评估包括患者因素 (年龄,并发症) 和手术类型.
- 根据出血风险类别,有针对暂停和恢复抗凝药的具体建议.
结论:
- 术后抗凝管理是一个复杂的,个性化的过程.
- 风险分层和了解抗凝固剂特性对于安全的患者护理至关重要.
- 护士是有效风险评估,患者教育和术后期监测的组成部分.
相关概念视频
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Venous Thrombosis IV: Nursing Management
202
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
202
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Peripheral Artery Disease V: Postoperative Nursing Management
378
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
378
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K

